Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1986 May;64(2):285–294.

Cell-mediated immunity to hepatitis B virus antigens in mice: correlation of in vivo and in vitro assays.

P A De Moerloose, I H Frazer, W A Sewell, E J Collins, I R Mackay
PMCID: PMC1542335  PMID: 3091300

Abstract

Cell mediated immunity (CMI) to hepatitis B viral antigens was studied in BALB/mice after immunization with purified hepatitis B surface antigen (HBsAg), or core antigen (HBcAg), with adjuvants. The two in vitro assays for cell-mediated immunity (CMI), utilizing lymph node cells, were release of interferon after exposure to antigen, and blast transformation of lymphocytes, and the in vivo assay was ear swelling at 24 h after local injection of antigen. Immunization with HBsAg or HBcAg with adjuvants induced antigen-specific cutaneous reactivity; if no adjuvants were given, immunization with HBcAg, but not HBsAg, induced cutaneous reactivity. CMI could be adoptively transferred by lymph node cells, but for only a limited period after immunization with HbsAg or HBcAg. The ability of lymph node cells from mice immunized with HBV antigens to transfer adoptively CMI correlated well with their production of interferon after challenge with antigen in vitro, but less well with blastogenesis after challenge with antigen in vitro, or with cutaneous reactivity to antigen in the donor mouse. Reliable antigen-specific lymphokine release assays, rather than blast transformation of lymphocytes or cutaneous reactivity after antigen challenge, are required to assess CMI to HBV antigens in the mouse and, by inference, in man.

Full text

PDF
285

Images in this article

290Fig. 1
on p.290

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andersson J., Möller G., Sjöberg O. Selective induction of DNA synthesis in T and B lymphocytes. Cell Immunol. 1972 Aug;4(4):381–393. doi: 10.1016/0008-8749(72)90040-8. [DOI] [PubMed] [Google Scholar]
  2. Fattovich G., Alberti A., Crivellaro C., Pontisso P., Noventa F., Realdi G. Cellular immunity to the hepatitis B virion in acute hepatitis type B. Clin Exp Immunol. 1983 Sep;53(3):645–650. [PMC free article] [PubMed] [Google Scholar]
  3. Gerety R. J., Hoofnagle J. H., Barker L. F. Humoral and cell-mediated immune responses to two hepatitis B virus antigens in guinea pigs. J Immunol. 1974 Oct;113(4):1223–1229. [PubMed] [Google Scholar]
  4. Hilleman M. R., McAleer W. J., Buynak E. B., McLean A. A. The preparation and safety of hepatitis B vaccine. J Infect. 1983 Jul;7 (Suppl 1):3–8. doi: 10.1016/s0163-4453(83)96465-4. [DOI] [PubMed] [Google Scholar]
  5. Ibrahim A. B., Vyas G. N., Prince A. M. Studies on delayed hypersensitivity to hepatitis B antigen in chimpanzees. Clin Exp Immunol. 1974 Jun;17(2):311–318. [PMC free article] [PubMed] [Google Scholar]
  6. Irwin G. R., Jr, Hierholzer W. J., Jr, Cimis R., McCollum R. W. Delayed hypersensitivity in hepatitis B: clinical correlates of in vitro production of migration inhibition factor. J Infect Dis. 1974 Dec;130(6):580–587. doi: 10.1093/infdis/130.6.580. [DOI] [PubMed] [Google Scholar]
  7. Klinman N. R., Press J. L. The B cell specificity repertoire: its relationship to definable subpopulations. Transplant Rev. 1975;24:41–83. doi: 10.1111/j.1600-065x.1975.tb00165.x. [DOI] [PubMed] [Google Scholar]
  8. Laiwah A. A., Chaudhuri A. K., Anderson J. R. Lymphocyte transformation and leucocyte migration-inhibition by Australia antigen. Clin Exp Immunol. 1973 Sep;15(1):27–34. [PMC free article] [PubMed] [Google Scholar]
  9. McKimm-Breschkin J. L., Holmes I. H. Conditions required for induction of interferon by rotaviruses and for their sensitivity to its action. Infect Immun. 1982 Jun;36(3):857–863. doi: 10.1128/iai.36.3.857-863.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Milich D. R., Thornton G. B., Neurath A. R., Kent S. B., Michel M. L., Tiollais P., Chisari F. V. Enhanced immunogenicity of the pre-S region of hepatitis B surface antigen. Science. 1985 Jun 7;228(4704):1195–1199. doi: 10.1126/science.2408336. [DOI] [PubMed] [Google Scholar]
  11. Munoz J. J., Bernard C. C., Mackay I. R. Elicitation of experimental allergic encephalomyelitis (EAE) in mice with the aid of pertussigen. Cell Immunol. 1984 Jan;83(1):92–100. doi: 10.1016/0008-8749(84)90228-4. [DOI] [PubMed] [Google Scholar]
  12. Nagafuchi S., Kashiwagi S., Hayashi S., Inoue T., Imayama S., Takeshita M., Kikuchi M. Delayed type hypersensitivity (DTH) skin reaction to hepatitis B surface antigen (HBsAg) in patients with type B acute and chronic hepatitis. Clin Exp Immunol. 1985 Sep;61(3):569–576. [PMC free article] [PubMed] [Google Scholar]
  13. Reed W. D., Mitchell C. G., Eddleston A. L., Lee W. M., Williams R., Zuckerman A. J. Exposure and immunity to hepatitis-B virus in a liver unit. Lancet. 1974 Apr 6;1(7858):581–583. doi: 10.1016/s0140-6736(74)92646-4. [DOI] [PubMed] [Google Scholar]
  14. Roberts I. M., Bernard C. C., Vyas G. N., Mackay I. R. T-cell dependence of immune response to hepatitis B antigen in mice. Nature. 1975 Apr 17;254(5501):606–607. doi: 10.1038/254606a0. [DOI] [PubMed] [Google Scholar]
  15. Sabbe L. J., De Bode L., Van Rood J. J. Analysis of variability in lymphocyte transformation tests. J Immunol Methods. 1983 Feb 25;57(1-3):21–32. doi: 10.1016/0022-1759(83)90060-1. [DOI] [PubMed] [Google Scholar]
  16. Scaroni C., Cancellieri V., Vernace S., Paronetto F. Cell-mediated immunity to HBcAg and HBsAg in patients with chronic hepatitis. J Clin Lab Immunol. 1981 Jul;6(1):45–50. [PubMed] [Google Scholar]
  17. Sewell W. A., Munoz J. J., Vadas M. A. Enhancement of the intensity, persistence, and passive transfer of delayed-type hypersensitivity lesions by pertussigen in mice. J Exp Med. 1983 Jun 1;157(6):2087–2096. doi: 10.1084/jem.157.6.2087. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Tiku M. L., Beutner K. R., Tiku K., Ogra P. L. Cell-mediated immune response to liver tissue antigen and hepatitis B surface antigen after infection with hepatitis B virus in humans. J Infect Dis. 1978 Nov;138(5):587–596. doi: 10.1093/infdis/138.5.587. [DOI] [PubMed] [Google Scholar]
  19. Tong M. J., Wallace A. M., Peters R. L., Reynolds T. B. Lymphocyte stimulation in hepatitis B infections. N Engl J Med. 1975 Aug 14;293(7):318–322. doi: 10.1056/NEJM197508142930702. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES